Immuno-Biological Laboratories Co., Ltd. had a revenue of 289.42M in the quarter ending Mar 31, 2025, with 22.63%. This bring the company's revenue in the last twelve months to 969.41M, Decreased 2.23%. In the fiscal year ending Dec 31, 2024, Immuno-Biological Laboratories Co., Ltd. had annual revenue of 969.53M with 18.71% growth.